/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Cedar Fair Reports Strong Start to 2019
-
Company anticipates 2019 will yield its 10th
consecutive year of record-setting revenues, driven by investments in
new rides; multi-week, immersive entertainment offerings;
season-extending events; and data-driven marketing - Early-season sales for advance purchase commitments up double-digits
-
Board declares cash distribution of $0.925 per limited partner (LP)
unit payable on June 17, 2019
SANDUSKY, Ohio–(BUSINESS WIRE)–Cedar Fair Entertainment Company (NYSE: FUN), a leader in regional
amusement parks, water parks and immersive entertainment, today
announced results for the first quarter ended March 31, 2019, and due to
the later timing of the Easter and spring break holidays, the Company
provided an update on revenue trends through the first four months of
the year. Historically, first-quarter results represent less than 5% of
the Company’s full-year net revenues as the majority of its parks and
facilities are closed during the first quarter. As a result, the Company
typically operates at a loss during this three-month period.
Based on preliminary results for the first four months ended April 28,
2019, the Company indicated net revenues are up 2%, or approximately $2
million, when compared with the same prior-year period ended April 29,
2018, primarily a result of strong in-park guest spending and
out-of-park revenues.
“We are pleased with the start to the year and our early-season trends
through the first four months of the season, which for the most part
normalize for the spring break calendar shift associated with a later
Easter holiday,” said Richard Zimmerman, Cedar Fair’s president and CEO.
“Importantly, deferred revenues through the first four months of the
year are up 12%, or more than $20 million year-over-year, on the sale of
advance purchase commitments for 2019, including sales of season passes
and our all-season dining and beverage products. We believe our strong
early-season performance and positive outlook are attributable to the
outstanding job our teams have done to elevate the guest experience. For
instance, Knott’s Berry Farm in California is off to its strongest start
ever as its early-season PEANUTS Celebration and Boysenberry Festival
events continue to expand their offerings and guest appeal. Meanwhile,
in Charlotte, Carowinds’ newest world-class roller coaster, Copperhead
Strike, is quickly becoming a signature attraction in this growing and
attractive market, and the initial response to Canada’s Wonderland’s
newest coaster, Yukon Striker, has been even better than expected.”
Zimmerman stated that the Company is on track to achieve its long-term
Adjusted EBITDA target of $575 million by 2023 as it aggressively
pursues growth through multiple channels. This includes broadening and
enhancing the guest experience, expanding its season pass program,
increasing market penetration through targeted marketing efforts and
pursuing adjacent development.
First-Quarter Results
For the first quarter ended March 31, 2019, Cedar Fair’s net revenues
increased $12 million to $67 million, compared with $55 million last
year. The increase in revenues reflects increases in attendance, in-park
per capita spending and out-of-park revenues, all of which were up
meaningfully in the quarter due to an additional nine operating days,
compared with last year’s first quarter ended on March 25, 2018.
The operating loss for the quarter was in line with the Company’s
expectations at $85 million, compared with an operating loss of $76
million last year. The higher operating loss reflects a $14 million
increase in operating costs and expenses, which totaled $138 million for
the first quarter of 2019. The increase in operating costs and expenses
was in line with the Company’s expectations and was largely due to an
extra calendar week and the nine additional operating days in the
quarter.
Depreciation and amortization expenses for the first three months of
2019 were $14 million, an increase of $8 million compared with last
year, due to a change in the estimated useful life of a long-lived park
asset, as well as the additional week in the current-year period. The
loss on impairment/retirement of fixed assets in the current quarter was
comparable to last year’s first quarter.
Interest expense for the first quarter was $21 million, up slightly from
$20 million in 2018, due to the additional week in the current-year
period. The net effect of the Company’s swaps during the quarter
resulted in a $6 million charge to earnings in 2019 compared with a $4
million benefit to earnings in 2018. The difference reflects the change
in fair market value movements in the Company’s swap portfolio. During
the first quarter of 2019, the Company also recognized a $9 million net
benefit to earnings for foreign currency gains and losses related to the
U.S.-dollar denominated Canadian notes compared with a $10 million net
charge to earnings for the first quarter of 2018.
During the first three months of 2019, a tax benefit of $20 million was
recorded to account for publicly traded partnership taxes and income
taxes on the Company’s corporate subsidiaries. This is comparable to the
tax benefit recorded in the first three months of 2018.
The net loss for the 2019 first quarter totaled $84 million, or $1.49
per diluted LP unit. This is comparable with a net loss of $83 million,
or $1.49 per diluted LP unit, reported in 2018.
Cash Flow and Liquidity Remain Strong
As of March 31, 2019, the Company had $735 million of variable-rate term
debt, before giving consideration to fixed-rate interest rate swaps;
$950 million of fixed-rate debt, before reduction for debt issuance
costs and original issue discount; $120 million of borrowings under its
revolving credit facilities; and $60 million of cash and cash
equivalents on hand. The Company believes it is in a strong position to
produce future cash flows from operations that, combined with its credit
facilities, will be sufficient to meet working capital needs, debt
service, planned capital expenditures and distributions for the
foreseeable future.
Distribution Declaration
The Company also announced today the declaration of a cash distribution
of $0.925 per LP unit. The distribution will be paid on June 17, 2019,
to unitholders of record as of June 4, 2019. This distribution reflects
the Company’s confidence in its business model and long-term strategy
and is consistent with its targeted annual distribution rate of $3.70
per LP unit for 2019.
Outlook
“This is an exciting time of year for Cedar Fair, as all of our parks
begin full summer operations,” said Zimmerman. “Over the next several
months, we will be introducing even more immersive experiences to
attract incremental guests to our parks and create reasons for our loyal
season passholders to visit again and again. We are launching several
new events, including Grande Carnivale, a nightly parade and street
party featuring music and dancing, and authentic food, drinks and live
entertainment from around the world. Also new this year at several of
our parks is Monster Jam® Thunder AlleyTM, an
interactive experience featuring Monster Jam’s most popular trucks. And,
in addition to the excitement around a new coaster, our Canada’s
Wonderland team is looking forward to extending its operating season
with a new WinterFest celebration.”
Zimmerman also noted the Company has several major development projects
underway, scheduled to open in the fourth quarter of 2019. “As we
continue to focus on expanding our accommodations portfolio, we look
forward to cutting the ribbon later this year on a 129-room SpringHill
Suites hotel adjacent to our Carowinds park. The addition of this hotel
will provide our guests a convenient option for extending their stay at
the park while enhancing Carowinds’ position as a multi-day
destination,” said Zimmerman.
Set to open later this year at the Cedar Point Sports Center in Sandusky
is a new indoor sports facility located next to the successful outdoor
sports complex that opened in 2017. “The outdoor complex has had
overwhelming success, drawing athletes and their families from multiple
states for tournament play, and we believe the stage is set for the
indoor facility to be just as successful,” added Zimmerman. “Scheduled
to open in December, this new facility will allow us to expand our draw
in the very attractive and ever-growing amateur sports market.
“As our teams focus on readying the majority of our parks for opening
day, we are confident Cedar Fair is well positioned to deliver one of
our best years yet. As consumers continue to prioritize experiences over
possessions, we are confident the Company has the right strategy and
team in place to give visitors the premium guest experience they have
come to expect from Cedar Fair,” concluded Zimmerman.
Conference Call
The Company will host a conference call with analysts today, May 8,
2019, at 10 a.m. EDT, to further discuss 2019 first quarter results and
provide additional detail on its long-term outlook. The call will be
webcast live in “listen only” mode via the Cedar Fair website http://ir.cedarfair.com
under Investor Information / Events and Presentations. It will also be
available for replay starting at approximately 1 p.m. EDT, Wednesday,
May 8, 2019, until 11:59 p.m. EDT, Wednesday, May 22, 2019. In order to
access the replay of the earnings call by phone, please dial
844-512-2921 followed by the access code 2895700.
About Cedar Fair
Cedar Fair Entertainment Company (NYSE: FUN), one of the largest
regional amusement-resort operators in the world, is a publicly traded
partnership headquartered in Sandusky, Ohio. Focused on its mission to
make people happy by providing fun, immersive and memorable experiences,
the Company owns and operates 11 amusement parks, including its flagship
park, Cedar Point, along with two outdoor water parks, one indoor water
park and four hotels. It also operates an additional theme park under a
management contract. Its parks are located in Ohio, California, North
Carolina, South Carolina, Virginia, Pennsylvania, Minnesota, Missouri,
Michigan and Toronto, Ontario.
Forward-Looking Statements
Some of the statements contained in this news release constitute
“forward-looking statements” within the meaning of the safe harbor
provisions of the United States Private Securities Litigation Reform Act
of 1995, including statements as to the Company’s expectations, beliefs,
goals and strategies regarding the future. These statements may involve
risks and uncertainties that could cause actual results to differ
materially from those described in such statements. Although the Company
believes that the expectations reflected in such forward-looking
statements are reasonable, it can give no assurance that such
expectations will prove to have been correct, or that the Company’s
growth strategies will achieve the targeted results. Important factors,
including general economic conditions, adverse weather conditions,
competition for consumer leisure time and spending, unanticipated
construction delays, changes in the Company’s capital investment plans
and projects and other factors discussed from time to time by the
Company in reports filed with the Securities and Exchange Commission
(the “SEC”) could affect attendance at the Company’s parks and cause
actual results to differ materially from the Company’s expectations or
otherwise to fluctuate or decrease. Additional information on risk
factors that may affect the business and financial results of the
Company can be found in the Company’s Annual Report on Form 10-K and in
the filings of the Company made from time to time with the SEC. The
Company undertakes no obligation to correct or update any
forward-looking statements, whether as a result of new information,
future events or otherwise.
Note: Monster Jam® and Thunder AlleyTM
are registered and unregistered trademarks of Feld Entertainment, Inc.
This news release and prior releases are available online at http://ir.cedarfair.com
CEDAR FAIR, L.P. |
||||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS | ||||||||
(In thousands, except per unit amounts) |
||||||||
Three months ended | ||||||||
3/31/2019 | 3/25/2018 | |||||||
Net revenues: | ||||||||
Admissions | $ | 33,217 | $ | 26,721 | ||||
Food, merchandise and games | 24,704 | 21,055 | ||||||
Accommodations, extra-charge products and other | 9,056 | 6,951 | ||||||
66,977 | 54,727 | |||||||
Costs and expenses: | ||||||||
Cost of food, merchandise, and games revenues | 7,649 | 6,003 | ||||||
Operating expenses | 98,205 | 88,828 | ||||||
Selling, general and administrative | 31,666 | 28,682 | ||||||
Depreciation and amortization | 13,589 | 5,521 | ||||||
Loss on impairment / retirement of fixed assets, net | 1,424 | 1,340 | ||||||
Gain on sale of investment | (617 | ) | — | |||||
151,916 | 130,374 | |||||||
Operating loss | (84,939 | ) | (75,647 | ) | ||||
Interest expense | 20,920 | 19,762 | ||||||
Net effect of swaps | 6,379 | (3,628 | ) | |||||
Loss on early debt extinguishment | — | 1,073 | ||||||
(Gain) loss on foreign currency | (8,669 | ) | 10,094 | |||||
Other expense (income) | 89 | (349 | ) | |||||
Loss before taxes | (103,658 | ) | (102,599 | ) | ||||
Benefit for taxes | (19,985 | ) | (19,199 | ) | ||||
Net loss | (83,673 | ) | (83,400 | ) | ||||
Net loss allocated to general partner | (1 | ) | (1 | ) | ||||
Net loss allocated to limited partners | $ | (83,672 | ) | $ | (83,399 | ) | ||
Basic loss per limited partner unit: | ||||||||
Weighted average limited partner units outstanding | 56,310 | 56,150 | ||||||
Net loss per limited partner unit | $ | (1.49 | ) | $ | (1.49 | ) | ||
Diluted loss per limited partner unit: | ||||||||
Weighted average limited partner units outstanding | 56,310 | 56,150 | ||||||
Net loss per limited partner unit | $ | (1.49 | ) | $ | (1.49 | ) | ||
CEDAR FAIR, L.P. | ||||||||
UNAUDITED BALANCE SHEET DATA | ||||||||
(In thousands) |
||||||||
3/31/2019 | 3/25/2018 | |||||||
Cash and cash equivalents | $ | 60,272 | $ | 42,888 | ||||
Total assets | $ | 2,132,470 | $ | 2,004,591 | ||||
Long-term debt, including current maturities: | ||||||||
Revolving credit loans | $ | 120,000 | $ | 40,000 | ||||
Term debt | 725,668 | 723,525 | ||||||
Notes | 938,407 | 937,257 | ||||||
$ | 1,784,075 | $ | 1,700,782 | |||||
Total partners’ equity | $ | (109,598 | ) | $ | (50,963 | ) | ||
CEDAR FAIR, L.P. |
||||||||
RECONCILIATION OF ADJUSTED EBITDA | ||||||||
(In thousands) |
||||||||
Three months ended | ||||||||
(In thousands) | 3/31/2019 | 3/25/2018 | ||||||
Net loss | $ | (83,673 | ) | $ | (83,400 | ) | ||
Interest expense | 20,920 | 19,762 | ||||||
Interest income | (233 | ) | (226 | ) | ||||
Benefit for taxes | (19,985 | ) | (19,199 | ) | ||||
Depreciation and amortization | 13,589 | 5,521 | ||||||
EBITDA | (69,382 | ) | (77,542 | ) | ||||
Loss on early debt extinguishment | — | 1,073 | ||||||
Net effect of swaps | 6,379 | (3,628 | ) | |||||
Non-cash foreign currency (gain) loss | (8,664 | ) | 10,098 | |||||
Non-cash equity compensation expense | 2,543 | 2,968 | ||||||
Loss on impairment / retirement of fixed assets, net | 1,424 | 1,340 | ||||||
Gain on sale of investment | (617 | ) | — | |||||
Other (1) | 159 | 169 | ||||||
Adjusted EBITDA (2) | $ | (68,158 | ) | $ | (65,522 | ) | ||
(1) |
Consists of certain costs as defined in the Company’s Amended 2017 Credit Agreement and prior credit agreements. These items are excluded in the calculation of Adjusted EBITDA and have included certain legal expenses, costs associated with certain ride abandonment or relocation expenses, and severance expenses. This balance also includes unrealized gains and losses on short-term investments. |
|
(2) |
Adjusted EBITDA represents earnings before interest, taxes, |
Contacts
Michael Russell
419.627.2233
https://ir.cedarfair.com
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Cannabis
Medical Cannabis Market Report 2024-2030: Asia-Pacific Set to Witness Robust Growth, Driven by R&D Discovery Initiatives
Cannabis
Rubicon Organics Reports Q1 2024 Financial Results
SCHWAZZE
Schwazze Announces First Quarter 2024 Financial Results
Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time
DENVER, May 15, 2024 /PRNewswire/ — Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) (“Schwazze” or the “Company”), today announced financial and operational results for the first quarter ended March 31, 2024.
“We delivered another period of revenue growth in Q1 as we further refined our retail strategy while contending with the prolonged competitive challenges in Colorado and New Mexico,” said Forrest Hoffmaster, Interim CEO of Schwazze. “Throughout the quarter, we continued to sharpen our pricing and promotional efforts while enhancing the in-store experience, widening assortment, improving in-stock position, and advancing our loyalty program to attract and retain new customers. We also strengthened our wholesale business with quarter-over-quarter growth, while surpassing 30% total door penetration across both states.”
“The Colorado market remains highly competitive with more than 680 active recreational licenses, underscoring the importance of delivering an exceptional customer experience and fully integrated retail support program. Although retail pricing has recently stabilized, Colorado sales in Q1 were down 10% year-over-year due to lower volumes. Nonetheless, we significantly outpaced the market as our sales were up 9%, demonstrating the effectiveness of our operating playbook to compete in challenging environments. We expect to continue driving improvements in customer acquisition, retention, and loyalty as we further increase market share in the state.”
“In New Mexico, the proliferation of new licenses continued to outpace state cannabis sales as store count in Q1 increased 31% year-over-year while the market grew only 13%. In addition to pricing and promotional efforts, we’ve focused on driving traffic into our stores by expanding assortment with high quality flower and delivering an elevated customer experience. The New Mexico regulatory body has also increased its license enforcement efforts in recent months, contributing to more than 70 store closures and a 33% sequential decrease in net new store openings in the first quarter. We will continue to support the New Mexico Cannabis Control Division as it develops its regulatory framework.”
“Over the past four years we have rapidly scaled our footprint through 13 acquisitions, building a leading retail presence in both Colorado and New Mexico. We are beginning to see positive momentum from our pricing and promotional strategy and will remain focused on driving operating efficiencies while further optimizing our assets as we consolidate cultivation facilities and eliminate underperforming stores that do not meet our high-margin thresholds. We believe these initiatives, coupled with our operating playbook and strict cost controls, will enable us to return to stronger levels of profitability moving forward.”
First Quarter 2024 Financial Summary
$ in Thousands USD |
Q1 2024 |
Q4 2023 |
Q1 2023 |
Total Revenue |
$41,601 |
$43,325 |
$40,001 |
Gross Profit |
$17,934 |
$7,034[1] |
$21,849 |
Operating Expenses |
$20,643 |
$23,276 |
$16,199 |
Income (Loss) from Operations |
$(2,709) |
$(16,242) |
$5,650 |
Adjusted EBITDA[2] |
$7,341 |
$10,953 |
$14,525 |
Operating Cash Flow |
$(3,700) |
$3,452 |
$(880) |
Recent Highlights
- Announced the grand opening of a medical and recreational dispensary in March under the Everest Apothecary banner in Las Cruces, New Mexico, increasing the Company’s retail footprint to 34 stores across the state.
- Increased wholesale penetration in the first quarter to more than 30% of total doors in Colorado and New Mexico.
- Lowell Herb Co. pre-roll sales increased more than 3x quarter-over-quarter in Colorado, where it continues to be the #1 pre-roll in the state.
- Wana gummy sales up more than 2x quarter-over-quarter in New Mexico.
First Quarter 2024 Financial Results
Total revenue in the first quarter of 2024 increased 4% to $41.6 million compared to $40.0 million for the same quarter last year. The increase was primarily due to growth from new stores compared to the prior year period, partially offset by continued pricing pressure and the proliferation of new licenses in New Mexico.
Gross profit for the first quarter of 2024 was $17.9 million or 43.1% of total revenue, compared to $21.8 million or 54.6% of total revenue for the same quarter last year. The decrease in gross margin was primarily driven by the aforementioned pricing pressure in New Mexico, as well as higher medical sales mix in Colorado.
____________________________ |
1 Q4 2023 Gross Profit includes one-time, non-cash inventory adjustments of approximately $13.1 million comprised of $3.1 million of product consolidation, obsolescence, and shrinkage expenses, $4.3 million of net realizable value adjustments, and $5.8 million of fair value adjustments on acquired inventory in New Mexico in 2023. |
Operating expenses for the first quarter of 2024 were $20.6 million compared to $16.2 million for the same quarter last year. The year-ago period benefitted from a payroll tax credit of $3.9M. The remaining increase was primarily driven by personnel expenses and four-wall SG&A costs associated with 21 additional stores in Colorado and New Mexico that are still ramping.
Loss from operations for the first quarter of 2024 was $2.7 million compared to income from operations of $5.6 million in the same quarter last year. Net loss was $16.1 million for the first quarter of 2024 compared to net income of $1.7 million for the same quarter last year.
Adjusted EBITDA for the first quarter of 2024 was $7.3 million compared to $14.5 million for the same quarter last year. The decrease in Adjusted EBITDA was primarily driven by lower gross margin and higher operating expenses associated with the 21 additional stores that are still ramping.
As of March 31, 2024, cash and cash equivalents were $13.2 million compared to $19.2 million on December 31, 2023. Total debt as of March 31, 2024, was $159.7 million compared to $156.8 million on December 31, 2023.
Conference Call
The Company will conduct a conference call today, May 15, 2024, at 5:00 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2024.
Schwazze management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing [email protected].
Date: Wednesday, May 15, 2024
Time: 5:00 p.m. Eastern time
Toll-free dial-in: (888) 664-6383
International dial-in: (416) 764-8650
Conference ID: 84167910
Webcast: SHWZ Q1 2024 Earnings Call
The conference call will also be broadcast live and available for replay on the investor relations section of the Company’s website at https://ir.schwazze.com.
Toll-free replay number: (888) 390-0541
International replay number: (416) 764-8677
Replay ID: 167910
If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.
About Schwazze
Schwazze (OTCQX: SHWZ) (Cboe CA: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to explore taking its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale.
Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector.
Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth. To learn more about Schwazze, visit https://schwazze.com/.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include financial outlooks; any projections of net sales, earnings, or other financial items; any statements of the strategies, plans and objectives of our management team for future operations; expectations in connection with the Company’s previously announced business plans; any statements regarding future economic conditions or performance; and statements regarding the intent, belief or current expectations of our management team. Such statements may be preceded by the words “may,” “will,” “could,” “would,” “should,” “expect,” “intends,” “plans,” “strategy,” “prospects,” “anticipate,” “believe,” “approximately,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other words of similar meaning in connection with a discussion of future events or future operating or financial performance, although the absence of these words does not necessarily mean that a statement is not forward-looking. We have based our forward-looking statements on management’s current expectations and assumptions about future events and trends affecting our business and industry. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. Therefore, forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) regulatory limitations on our products and services and the uncertainty in the application of federal, state, and local laws to our business, and any changes in such laws; (ii) our ability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (iii) our ability to identify, consummate, and integrate anticipated acquisitions; (iv) general industry and economic conditions; (v) our ability to access adequate capital upon terms and conditions that are acceptable to us; (vi) our ability to pay interest and principal on outstanding debt when due; (vii) volatility in credit and market conditions; (viii) the loss of one or more key executives or other key employees; and (ix) other risks and uncertainties related to the cannabis market and our business strategy. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.
Investor Relations Contact
Sean Mansouri, CFA or Aaron D’Souza
Elevate IR
(720) 330-2829
[email protected]
MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
For the Periods Ended March 31, 2024 and December 31, 2023
Expressed in U.S. Dollars
March 31, |
December 31, |
||||
2024 |
2023 |
||||
ASSETS
|
|||||
Current Assets |
|||||
Cash & Cash Equivalents |
$ |
13,151,317 |
$ |
19,248,932 |
|
Accounts Receivable, net of Allowance for Doubtful Accounts |
3,356,032 |
4,261,159 |
|||
Inventory |
26,382,184 |
25,787,793 |
|||
Marketable Securities, net of Unrealized Loss of $347,516 and Loss of $1,816, respectively |
108,583 |
456,099 |
|||
Prepaid Expenses & Other Current Assets |
3,502,310 |
3,914,064 |
|||
Total Current Assets |
46,500,426 |
53,668,047 |
|||
Non-Current Assets |
|||||
Fixed Assets, net Accumulated Depreciation of $10,061,700 and $8,741,782, respectively |
31,326,000 |
31,113,630 |
|||
Investments |
2,000,000 |
2,000,000 |
|||
Investments Held for Sale |
– |
202,111 |
|||
Goodwill |
67,492,705 |
67,499,199 |
|||
Intangible Assets, net Accumulated Amortization of $36,483,160 and $32,706,765, respectively |
162,391,482 |
166,167,877 |
|||
Other Non-Current Assets |
1,328,187 |
1,263,837 |
|||
Operating Lease Right of Use Assets |
34,575,832 |
34,233,142 |
|||
Deferred Tax Assets, net |
992,144 |
1,996,489 |
|||
Total Non-Current Assets |
300,106,350 |
304,476,285 |
|||
Total Assets |
$ |
346,606,776 |
$ |
358,144,332 |
|
LIABILITIES & STOCKHOLDERS’ EQUITY
|
|||||
Current Liabilities |
|||||
Accounts Payable |
$ |
9,443,233 |
$ |
13,341,561 |
|
Accrued Expenses |
8,106,618 |
7,774,691 |
|||
Derivative Liabilities |
1,319,845 |
638,020 |
|||
Lease Liabilities – Current |
5,186,316 |
4,922,724 |
|||
Current Portion of Long Term Debt |
29,579,713 |
3,547,011 |
|||
Income Taxes Payable |
28,235,039 |
25,232,782 |
|||
Total Current Liabilities |
81,870,764 |
55,456,789 |
|||
Non-Current Liabilities |
|||||
Long Term Debt, net of Debt Discount & Issuance Costs |
130,120,753 |
153,262,203 |
|||
Lease Liabilities – Non-Current |
30,735,072 |
30,133,452 |
|||
Total Non-Current Liabilities |
160,855,825 |
183,395,655 |
|||
Total Liabilities |
$ |
242,726,589 |
$ |
238,852,444 |
|
Stockholders’ Equity |
|||||
Preferred Stock, $0.001 Par Value. 10,000,000 Shares Authorized; 82,185 Shares Issued and |
|||||
82,185 Outstanding as of March 31, 2024 and 85,534 Shares Issued and 85,534 Outstanding as of |
|||||
December 31, 2023. |
82 |
86 |
|||
Common Stock, $0.001 Par Value. 250,000,000 Shares Authorized; 79,168,539 Shares Issued |
|||||
and 78,248,389 Shares Outstanding as of March 31, 2024 and 74,888,392 Shares Issued |
|||||
and 73,968,242 Shares Outstanding as of December 31, 2023. |
79,169 |
74,888 |
|||
Additional Paid-In Capital |
202,677,665 |
202,040,968 |
|||
Accumulated Deficit |
(96,843,602) |
(80,790,927) |
|||
Common Stock Held in Treasury, at Cost, 920,150 Shares Held as of March 31, 2024 and |
|||||
920,150 Shares Held as of December 31, 2023. |
(2,033,127) |
(2,033,127) |
|||
Total Stockholders’ Equity |
103,880,187 |
119,291,888 |
|||
Total Liabilities & Stockholders’ Equity |
$ |
346,606,776 |
$ |
358,144,332 |
MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME AND (LOSS)
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars
For the Three Months Ended |
|||||
March 31, |
|||||
2024 |
2023 |
||||
(Unaudited) |
(Unaudited) |
||||
Operating Revenues |
|||||
Retail |
$ |
37,633,252 |
$ |
35,820,111 |
|
Wholesale |
3,898,320 |
4,058,925 |
|||
Other |
69,421 |
121,900 |
|||
Total Revenue |
41,600,993 |
40,000,936 |
|||
Total Cost of Goods & Services |
23,667,319 |
18,152,163 |
|||
Gross Profit |
17,933,674 |
21,848,773 |
|||
Operating Expenses |
|||||
Selling, General and Administrative Expenses |
11,835,818 |
10,100,934 |
|||
Professional Services |
1,671,881 |
1,187,364 |
|||
Salaries |
6,880,988 |
4,695,971 |
|||
Stock Based Compensation |
253,916 |
214,544 |
|||
Total Operating Expenses |
20,642,603 |
16,198,813 |
|||
Income from Operations |
(2,708,929) |
5,649,960 |
|||
Other Income (Expense) |
|||||
Interest Expense, net |
(8,307,369) |
(7,745,854) |
|||
Unrealized Gain (Loss) on Derivative Liabilities |
(681,825) |
8,501,685 |
|||
Other Loss |
10,500 |
– |
|||
Loss on Investment |
(33,382) |
– |
|||
Unrealized Gain on Investment |
(347,516) |
1,816 |
|||
Total Other Income (Expense) |
(9,359,592) |
757,647 |
|||
Pre-Tax Net Income (Loss) |
(12,068,521) |
6,407,607 |
|||
Provision for Income Taxes |
3,984,154 |
4,662,178 |
|||
Net Income (Loss) |
$ |
(16,052,675) |
$ |
1,745,429 |
|
Less: Accumulated Preferred Stock Dividends for the Period |
(2,155,259) |
(2,029,394) |
|||
Net Income (Loss) Attributable to Common Stockholders |
$ |
(18,207,934) |
$ |
(283,965) |
|
Earnings (Loss) per Share Attributable to Common Stockholders |
|||||
Basic Earnings (Loss) per Share |
$ |
(0.24) |
$ |
(0.01) |
|
Diluted Earnings (Loss) per Share |
$ |
(0.24) |
$ |
(0.06) |
|
Weighted Average Number of Shares Outstanding – Basic |
76,006,932 |
55,835,501 |
|||
Weighted Average Number of Shares Outstanding – Diluted |
76,006,932 |
101,608,278 |
|||
Comprehensive Income (Loss) |
$ |
(16,052,675) |
$ |
1,745,429 |
MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars
For the Three Months Ended |
|||||
March 31, |
|||||
2024 |
2023 |
||||
(Unaudited) |
(Unaudited) |
||||
Cash Flows from Operating Activities: |
|||||
Net Income (Loss) for the Period |
$ |
(16,052,675) |
$ |
1,745,429 |
|
Adjustments to Reconcile Net Income (Loss) to Cash for Operating Activities |
|||||
Depreciation & Amortization |
5,096,314 |
6,151,395 |
|||
Non-Cash Interest Expense |
1,031,431 |
991,184 |
|||
Non-Cash Lease Expense |
2,871,226 |
2,251,459 |
|||
Deferred Taxes |
1,004,345 |
(637,225) |
|||
Loss on Investment |
202,111 |
– |
|||
Change in Derivative Liabilities |
681,825 |
(8,501,685) |
|||
Amortization of Debt Issuance Costs |
421,512 |
421,513 |
|||
Amortization of Debt Discount |
2,303,246 |
1,999,933 |
|||
(Gain) Loss on Investments, net |
347,516 |
(1,816) |
|||
Stock Based Compensation |
640,974 |
214,544 |
|||
Changes in Operating Assets & Liabilities (net of Acquired Amounts): |
|||||
Accounts Receivable |
905,127 |
(118,181) |
|||
Inventory |
(587,900) |
(3,023,251) |
|||
Prepaid Expenses & Other Current Assets |
411,754 |
(3,036,801) |
|||
Other Assets |
(64,350) |
360,674 |
|||
Change in Operating Lease Liabilities |
(2,348,703) |
(1,531,765) |
|||
Accounts Payable & Other Liabilities |
(3,566,401) |
(3,464,671) |
|||
Income Taxes Payable |
3,002,257 |
5,299,403 |
|||
Net Cash Provided by (Used in) Operating Activities |
(3,700,390) |
(879,861) |
|||
Cash Flows from Investing Activities: |
|||||
Collection of Notes Receivable |
– |
10,631 |
|||
Purchase of Fixed Assets |
(1,532,287) |
(2,913,394) |
|||
Net Cash Provided by (Used in) Investing Activities |
(1,532,287) |
(2,902,763) |
|||
Cash Flows from Financing Activities: |
|||||
Payment on Notes Payable |
(864,938) |
– |
|||
Net Cash Provided by (Used in) Financing Activities |
(864,938) |
– |
|||
Net (Decrease) in Cash & Cash Equivalents |
(6,097,615) |
(3,782,624) |
|||
Cash & Cash Equivalents at Beginning of Period |
19,248,932 |
38,949,253 |
|||
Cash & Cash Equivalents at End of Period |
$ |
13,151,317 |
$ |
35,166,628 |
|
Supplemental Disclosure of Cash Flow Information: |
|||||
Cash Paid for Interest |
$ |
4,515,205 |
$ |
6,540,748 |
MEDICINE MAN TECHNOLOGIES, INC.
ADJUSTED EBITDA RECONCILIATION (NON-GAAP)
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars
For the Three Months Ended |
|||||
March 31, |
|||||
2024 |
2023 |
||||
Net Income (Loss) |
$ |
(16,052,675) |
$ |
1,745,429 |
|
Interest Expense, net |
8,307,369 |
7,745,854 |
|||
Provision for Income Taxes |
3,984,154 |
4,662,178 |
|||
Other (Income) Expense, net of Interest Expense |
1,052,223 |
(8,503,501) |
|||
Depreciation & Amortization |
5,618,834 |
6,612,814 |
|||
Earnings Before Interest, Taxes, Depreciation and |
|||||
Amortization (EBITDA) (non-GAAP) |
$ |
2,909,905 |
$ |
12,262,774 |
|
Non-Cash Stock Compensation |
253,916 |
214,544 |
|||
Deal Related Expenses |
637,761 |
1,195,802 |
|||
Capital Raise Related Expenses |
20,760 |
35,068 |
|||
Severance |
484,561 |
118,436 |
|||
Retention Program Expenses |
807,500 |
280,632 |
|||
Pre-Operating & Dark Carry Expenses |
1,053,837 |
391,917 |
|||
One-Time Legal Settlements |
417,653 |
– |
|||
Other Non-Recurring Items |
754,751 |
25,707 |
|||
Adjusted EBITDA (non-GAAP) |
$ |
7,340,644 |
$ |
14,524,880 |
|
Revenue |
41,600,993 |
40,000,936 |
|||
Adjusted EBITDA Percent |
17.6 % |
36.3 % |
View original content:https://www.prnewswire.co.uk/news-releases/schwazze-announces-first-quarter-2024-financial-results-302146858.html
-
Cannabis1 week ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis1 week ago
IM Cannabis Reports First Quarter Financial Results
-
Innocan1 week ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis5 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
Cannabis5 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis4 days ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
-
Cannabis3 days ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032
-
SCHWAZZE3 days ago
Schwazze Announces First Quarter 2024 Financial Results